RxWatch News and Information

FDA Issues Recall of Perrigo Albuterol Inhalers

Lawsuit News from OnderLaw

Inhalers recalled after thousands of reports of clogged inhalers.

Monday, September 28, 2020 - The U.S. Food and Drug Administration has issued a voluntary recall of Perrigo Pharmaceutical albuterol sulfate inhalers manufactured by Catalent Pharma Solutions after the company received several thousand complaints of the product clogging and keeping patients from receiving adequate or any medication. Many of the inhalers have worked initially, but stopped working or became clogged after several uses.

Patients using Perrigo albuterol inhalers are urged to continue using them, but to also keep additional inhalers on hand. Inhalers are available from other manufacturers.

Additional recommendations by the FDA for patients include immediately seeking medical emergency care if needed, and contacting their physician or pharmacist with questions.

Albuterol inhalers deliver medications to open airways in patients being treated for asthma, COPD, and other breathing conditions. These inhalers are often used in emergency situations, and failure due to clogging can put patients at unnecessary risk.

Catalent, Perrigo's product manufacturer, stopped production and distribution of albuterol inhalers August 21, 2020. The FDA reports indicate that the company is investigating the malfunction.

If you or a loved one has sustained serious injury or death due to malfunction of an albuterol inhaler, contact the medical device attorneys at OnderLaw at 314-963-9000. OnderLaw attorneys represent thousands of clients who have suffered when companies put profits over safety of the people who use them. Call today for a free, no-obligation consultation. Our attorneys do not get paid unless you win your case.

Tags for This Article:

product recallsmedical devices

More Recent Lawsuit News:

No-Cost, No-Obligation Case Review.

OnderLaw, LLC in St. Louis has developed a solid reputation of excellence as a personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. OnderLaw has represented clients throughout the United States in pharmaceutical and medical device litigation, including Pradaxa, Lexapro and Yasmin/Yaz, Actos, Risperdal and others. OnderLaw has won verdicts of more than $300 million in talcum powder ovarian cancer lawsuits and represent more Glyphosate victims than any other firm in the country.

Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards Onder Law Trial Awards